Saint Luke's Radiation Oncology Network

At Saint Luke's Radiation Oncology Network in Dublin, a major focus is on head and neck cancers within oncology and radiation therapy. Trials are studying advanced disease, including oropharyngeal cancer and squamous cell carcinoma of the head and neck, with the goal of improving survival, reducing recurrence, and finding better treatment combinations.

• Testing whether adding new therapies to radiotherapy can improve outcomes in locally advanced head and neck cancer
• Comparing treatment approaches to extend survival in oropharyngeal cancer
• Evaluating side effects, swallowing function, and quality of life alongside cancer control

This research also explores how to balance effectiveness with tolerability, especially for older patients and those with advanced disease.

Another important area at this clinical research site is prostate cancer, spanning localized high-risk disease and metastatic hormone-sensitive prostate cancer. The studies are examining whether adding new hormone-based treatments to standard care can improve survival and delay progression.

• Assessing treatment strategies for localized very high-risk prostate cancer
• Studying approaches for metastatic hormone-sensitive prostate cancer
• Testing whether new combinations can improve cancer control when used with androgen deprivation therapy and radiation therapy

These trials aim to strengthen long-term disease control while supporting better outcomes for men with aggressive prostate cancer.

The site is also involved in broader cancer research across neoplasms, including studies in breast cancer, colon cancer, rectal cancer, stomach cancer, and oesophageal cancer. This work focuses on helping prevent recurrence and improving survival after standard treatment.

• Exploring whether aspirin use after treatment can reduce the chance of cancer returning
• Studying survival outcomes in people with common non-metastatic solid tumours
• Supporting research into long-term disease control after primary therapy

These investigations reflect a strong interest in finding practical ways to improve outcomes across several common cancers.

Within analytical, diagnostic and therapeutic techniques and equipment, the trials at Saint Luke's Radiation Oncology Network are refining how cancer treatment is delivered. The emphasis is on making established therapies more effective and less toxic through better treatment selection and combination strategies.

• Comparing different cisplatin and radiation schedules for head and neck cancer
• Evaluating treatment intensification approaches for patients with higher-risk disease
• Measuring outcomes such as survival, recurrence, and treatment-related side effects

Overall, the research portfolio shows a clear commitment to improving the effectiveness, safety, and quality of cancer care across multiple disease areas.